Mobile Trading

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE881.90-10.5 (-1.18 %)
PREV CLOSE ( ) 892.40
OPEN PRICE ( ) 896.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15812
TODAY'S LOW / HIGH ( )864.20 901.75
52 WK LOW / HIGH ( )530.7 1675.25
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)389.90-7.68-22.44-51.2529.93
   CEPS(Rs)65.287.591.37-26.8750.19
   DPS(Rs)4.002.501.500.002.50
   Book NAV/Share(Rs)276.83230.95242.83262.48309.09
   Tax Rate(%)15.92-25.3619.3227.3211.49
Margin Ratios
   Core EBITDA Margin(%)11.259.406.17-0.4011.45
   EBIT Margin(%)10.382.72-0.40-8.937.77
   Pre Tax Margin(%)6.87-1.89-4.58-12.255.03
   PAT Margin (%)5.77-2.36-3.70-8.904.45
   Cash Profit Margin (%)8.481.150.20-4.538.22
Performance Ratios
   ROA(%)7.21-2.41-3.52-6.993.82
   ROE(%)17.52-6.67-10.15-18.499.21
   ROCE(%)16.563.47-0.49-9.499.08
   Asset Turnover(x)1.251.020.950.780.86
   Sales/Fixed Asset(x)2.461.961.911.752.04
   Working Capital/Sales(x)13.9867.8543.06-106.8869.38
Efficiency Ratios
   Fixed Capital/Sales(x)0.410.510.520.570.49
   Receivable days60.3573.1773.2579.4168.09
   Inventory Days61.8668.1267.8081.3566.13
   Payable days173.66191.36230.40267.95264.54
Valuation Parameters
   PER(x)1.720.000.000.0028.21
   PCE(x)10.25103.13209.18-12.9016.83
   Price/Book(x)2.423.391.181.322.73
   Yield(%)0.600.320.520.000.30
   EV/Net Sales(x)1.712.421.371.862.86
   EV/Core EBITDA(x)9.0815.149.6951.0913.84
   EV/EBIT(x)10.6356.91-201.23-12.0122.32
   EV/CE(x)1.802.071.010.851.39
   M Cap / Sales1.351.850.701.012.28
Growth Ratio
   Net Sales Growth(%)17.365.4720.13-7.4120.49
   Core EBITDA Growth(%)38.4919.51365.23-83.7020.61
   EBIT Growth(%)344.76760.2094.73-211.81102.24
   PAT Growth(%)384.5037.6851.31-294.53462.28
   EPS Growth(%)5174.4765.7656.22-271.23636.70
Financial Stability Ratios
   Total Debt/Equity(x)0.701.141.271.180.76
   Current Ratio(x)1.201.031.050.991.03
   Quick Ratio(x)0.700.640.670.640.59
   Interest Cover(x)2.960.59-0.10-2.692.84
   Total Debt/Mcap(x)0.290.341.070.900.28

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.